SpringerLink
Log in

Targeting NRP1 axis as a strategy for treating energy metabolism impairment induced by SARS-CoV-2 spike

  • Letter to the Editor
  • Published:
Science China Life Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price includes VAT (France)

Instant access to the full article PDF.

Institutional subscriptions

References

  • Lei, Y., Zhang, J., Schiavon, C.R., He, M., Chen, L., Shen, H., Zhang, Y., Yin, Q., Cho, Y., Andrade, L., et al. (2021). SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE 2. Circ Res 128, 1323–1326.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yang, K., Liu, S., Yan, H., Lu, W., Shan, X., Chen, H., Bao, C., Feng, H., Liao, J., Liang, S., et al. (2023). SARS-CoV-2 spike protein receptor-binding domain perturbates intracellular calcium homeostasis and impairs pulmonary vascular endothelial cells. Sig Transduct Target Ther 8, 276.

    Article  CAS  Google Scholar 

  • Cantuti-Castelvetri, L., Ojha, R., Pedro, L.D., Djannatian, M., Franz, J., Kuivanen, S., van der Meer, F., Kallio, K., Kaya, T., Anastasina, M., et al. (2020). Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 370, 856–860.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Daly, J.L., Simonetti, B., Klein, K., Chen, K.E., Williamson, M.K., Antón-Plágaro, C., Shoemark, D.K., Simón-Gracia, L., Bauer, M., Hollandi, R., et al. (2020). Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science 370, 861–865.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Talotta, R. (2022). Impaired VEGF-A-mediated neurovascular crosstalk induced by SARS-CoV-2 spike protein: a potential hypothesis explaining long COVID-19 symptoms and COVID-19 vaccine side effects? Microorganisms 10, 2452.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kramer, R.M., and Sharp, J.D. (1997). Structure, function and regulation of Ca2+-sensitive cytosolic phospholipase A2 (cPLA2). FEBS Lett 410, 49–53.

    Article  CAS  PubMed  Google Scholar 

  • George, S., Pal, A.C., Gagnon, J., Timalsina, S., Singh, P., Vydyam, P., Munshi, M., Chiu, J.E., Renard, I., Harden, C.A., et al. (2021). Evidence for SARS-CoV-2 spike protein in the urine of COVID-19 patients. Kidney360 2, 924–936.

    Article  PubMed  PubMed Central  Google Scholar 

  • Chen, T.H., Chang, C.J., and Hung, P.H. (2023). Possible pathogenesis and prevention of long COVID: SARS-CoV-2-induced mitochondrial disorder. Int J Mol Sci 24, 8034.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yonker, L.M., Swank, Z., Bartsch, Y.C., Burns, M.D., Kane, A., Boribong, B.P., Davis, J.P., Loiselle, M., Novak, T., Senussi, Y., et al. (2023). Circulating spike protein detected in Post-COVID-19 mRNA vaccine myocarditis. Circulation 147, 867–876.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nunn, A.V.W., Guy, G.W., Brysch, W., and Bell, J.D. (2022). Understanding long COVID; mitochondrial health and adaptation—old pathways, new problems. Biomedicines 10, 3113.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgement

This work was supported by the National Natural Science Foundation of China (82141218), Young Elite Scientists Sponsorship Program by CAST (2022QNRC001) and National Key Research and Development Program of China (2022YFC3500304).

Author information

Authors and Affiliations

  1. Bei**g Institute of Pharmacology & Toxicology, Bei**g, 100850, China

    Lihui Zhang, Wanting Hu, **gxuan Li, Yuehan Li, Feng Liu, Wenyi **ao, Ning Jiang, Zhiyong **ao, Lu Han & Wenxia Zhou

  2. State Key Laboratory of Toxicology and Medical Countermeasures, Bei**g Institute of Pharmacology & Toxicology, Bei**g, 100850, China

    Lihui Zhang, Wanting Hu, **gxuan Li, Yuehan Li, Feng Liu, Wenyi **ao, Ning Jiang, Zhiyong **ao, Lu Han & Wenxia Zhou

  3. School of Chinese Materia Medica, Tian** University of Traditional Chinese Medicine, Tian**, 301617, China

    Lihui Zhang & Wenxia Zhou

Authors
  1. Lihui Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wanting Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. **gxuan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yuehan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Feng Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wenyi **ao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ning Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Zhiyong **ao
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Lu Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Wenxia Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Lu Han or Wenxia Zhou.

Supporting Information

11427_2023_2568_MOESM1_ESM.pdf

Supplementary Materials for Targeting NRP1 Axis as an Strategy for Treating Energy Metabolism Impairment Induced by SARS-CoV-2 Spike

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, L., Hu, W., Li, J. et al. Targeting NRP1 axis as a strategy for treating energy metabolism impairment induced by SARS-CoV-2 spike. Sci. China Life Sci. (2024). https://doi.org/10.1007/s11427-023-2568-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11427-023-2568-4

Search

Navigation